Ace Neuroscience Launches Drug Development Services for Stroke and Psychiatric Disorders
Ace Neuroscience, a preclinical CRO service provider engaged in the research of stroke and antipsychotic drug development, has announced the launch of its drug development services for stroke and psychiatric disorders. The company aims to leverage its expertise and cutting-edge technology to develop innovative treatments for these conditions.